APA

Claeys T., Lumen N., Kumps C., Praet M., De Meerleer G., Rottey S., Ost P., Devisschere P., Villeirs G., Fonteyne V. & Decaestecker K. (20180312). The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma: Prognostic features in the era of targeted therapies. : Urologic oncology.

Chicago

Claeys Tom, Lumen Nicolaas, Kumps Candy, Praet Marleen, De Meerleer Gert, Rottey Sylvie, Ost Piet, Devisschere Pieter, Villeirs Geert, Fonteyne Valerie and Decaestecker Karel. 20180312. The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma: Prognostic features in the era of targeted therapies. : Urologic oncology.

Harvard

Claeys T., Lumen N., Kumps C., Praet M., De Meerleer G., Rottey S., Ost P., Devisschere P., Villeirs G., Fonteyne V. and Decaestecker K. (20180312). The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma: Prognostic features in the era of targeted therapies. : Urologic oncology.

MLA

Claeys Tom, Lumen Nicolaas, Kumps Candy, Praet Marleen, De Meerleer Gert, Rottey Sylvie, Ost Piet, Devisschere Pieter, Villeirs Geert, Fonteyne Valerie and Decaestecker Karel. The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma: Prognostic features in the era of targeted therapies. : Urologic oncology. 20180312.